|
Volumn 9, Issue 2, 1999, Pages 291-294
|
Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran- 10: Phase II clinical trial data
a a b a c d e f g h i i |
Author keywords
Contrast medium; Iron oxides; MR imaging; Safety
|
Indexed keywords
FERUMOXTRAN 10;
ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTRAST ENHANCEMENT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DRUG SAFETY;
DYSPNEA;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER;
MAJOR CLINICAL STUDY;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RASH;
SPLEEN;
THORAX PAIN;
|
EID: 0033007861
PISSN: 10531807
EISSN: None
Source Type: Journal
DOI: 10.1002/(sici)1522-2586(199902)9:2<291::aid-jmri21>3.0.co;2-%23 Document Type: Article |
Times cited : (50)
|
References (8)
|